Phoenix PharmaLabs

Phoenix PharmaLabs is addressing the opioid crisis by developing a potent, safe, non-addictive painkiller.

Raise to date: $1,102,553

Reporting Date: 03/31/2019

Key Stats

Minimum Raise

$10,000

Maximum Raise

$1,070,000

Likelihood of Max Exceeded
Start Date

10/15/2018

Stop Date

03/30/2019

Days Remaining

Closed

Security Type

Common Stock

Investment Minimum

$1

Deal Type

Deal to Watch


Investment Summary

Status

Confirmed Closed

# of Investors

Not Known

% of Minimum Raised

11,026%

% of Maximum Raised

103%

Dollars Per Day to Reach Max

N/A

DPD* Committed

$6,642

DPD* Category

$2,152

DPD* All Companies

$956

Kingscrowd Momentum

$1,102,553

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

Phoenix PharmaLabs has created a safe and non-addictive painkiller that they hope will combat the opioid epidemic and crisis. This preclinical, potent treatment can be used for both pain and addiction treatment. So far, it’s been tested in animal studies to be effective, does not produce withdrawal, does not cause death from overdose, and does not cause constipation. The US Army and the NIH have already been provided a $3M grant, and with this campaign, Phoenix PharmaLabs hopes to accelerate the advancement of the drug and perform key studies in humans.

Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Phoenix PharmaLabs
Follow company
Follow Phoenix PharmaLabs
INVEST NOW

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Become an Informed Investor